Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

14.60
Delayed Data
As of Apr 24
 -0.35 / -2.34%
Today’s Change
11.90
Today|||52-Week Range
20.40
-3.95%
Year-to-Date

Today’s Trading

Previous close14.95
Today’s open15.00
Day’s range14.50 - 15.00
Volume356,152
Average volume (3 months)676,828
Market cap$904.2M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+14.63%
Earnings growth (this year)+294.29%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+13.06%
P/E ratioNM
Price/Sales4.12
Price/Book6.81

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc-0.10-1.39%
ACRSAclaris Therapeutics...+0.08+0.45%
FLXNFlexion Therapeutics...0.000.00%
RVNCRevance Therapeutics...-0.15-0.51%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$165.1M
Annual profit (last year)-$15.6M
Net profit margin-9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts